UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038041
Receipt number R000043366
Scientific Title A study to examine the effects of beef bowl intake on physical and mental fatigue
Date of disclosure of the study information 2019/10/01
Last modified on 2020/01/14 12:31:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to examine the effects of beef bowl intake on physical and mental fatigue

Acronym

A study to examine the effects of beef bowl intake on physical and mental fatigue

Scientific Title

A study to examine the effects of beef bowl intake on physical and mental fatigue

Scientific Title:Acronym

A study to examine the effects of beef bowl intake on physical and mental fatigue

Region

Japan


Condition

Condition

Healthy volunteer

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the effects of beef bowl intake on physical and mental fatigue.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Saliva test (S-IgA,cortisol),VAS (Visual Analogue Scale) before and after mental load and physical load

Key secondary outcomes

Fatigue measurement with equipment(VM500)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Visit1 beef bowl
Visit2 beef bowl
Visit3 other food
Visit4 other food

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >=

Gender

Male and Female

Key inclusion criteria

[1]Aged between 20 and 49
[2]Individuals who are healthy and do not treat any disease
[3]Individuals whose written informed consent has been obtained
[4]Individuals who can have an examination on a designated check day
[5]Individuals judged appropriate for the study by the principal

Key exclusion criteria

[1]Individuals using medical products
[2]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung disease,or blood disease
[3]Individuals with serious anemia
[4]Individuals who are sensitive to test products or Individual with fear who causes severe allergy in a food and medical supplies
[5]Individual who is pregnant or lactate
[6]Individuals who participated in other clinical studies in the past three months
[7]Individuals judged inappropriate for the study by the principal

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Yoshikazu
Middle name
Last name Yonei

Organization

Faculty of Life and Medical Sciences,Doshisha University

Division name

Anti-Aging Medical Research Center

Zip code

610-0394

Address

1-3 Tatara Miyakodani,Kyotanabe City,Kyoto

TEL

0774-65-6394

Email

yyonei@mail.doshisha.ac.jp


Public contact

Name of contact person

1st name Seigo
Middle name
Last name Isozaki

Organization

Anti-Aging Bank Co.,Ltd.

Division name

Clinical test support team

Zip code

101-0054

Address

3-21,Kanda-nishikicho,Chiyoda-ku,Tokyo

TEL

03-5577-1010

Homepage URL


Email

isozaki@antiaging-bank.com


Sponsor or person

Institute

Anti-Aging Bank Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

YOSHINOYA HOLDINGS CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Society of Glycative Stress Research

Address

5F-11,Musashino Bldg,2-13-10 Shinjuku,Shinjuku-ku,Tokyo

Tel

03-6709-8842

Email

rinri-glycativestress@antiaging-bank.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

同志社大学生命医科学部アンチエイジングリサーチセンター


Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 05 Day

Date of IRB

2019 Year 09 Month 24 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 09 Month 18 Day

Last modified on

2020 Year 01 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043366


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name